Your view is my view. Bitesr has some good thought, its just that he re-hashes the same old mantre over and over...which makes you wonder if he does work for a hedge fund. Given Bitesr's view Leo shouldn't even take a leak, and just use a catheter, he is so incompetent. We get you view Bite, Leo should just stay in bed. Personally, I think he is doing a great job on a shoe string budget, and rebuking the Mako / Rosen attack, but CTIX needs to get a partner. The P data / results is not hype. And if his PR's are liable, Rosen sure couldn't prove it. Give it a rest Bitesr.
The way you constantly post here makes me think you are unemployed, or if employed you are not doing your job, which you accuse Leo of not doing.. Holding a small position with such anger could also mean you are getting paid per post by a hedgefund with a large short position. The only other explanation is your certifiable, which Dr Yellen has diagnosed you to be, which is sounding like a very good diagnosis.
When he's right, which is often, you can make a lot of $$$. Looks like his call on AMGN is spot on.
Takeover attempt falls through. Reason I bring it up here is BMRN and GILD would be a perfect match. A rare disease drug maker with a tremendous pipeline and first genetic base coming therapy for hemophilia. They are more insulated from price controls than me too drug makers, all BMRN needs is more cash to drive the pipeline forward faster. Would like to see it stay with a U.S. Co. I thought GILD would be making some kind of move by now. The Biotech sector could be on a swing back and all the Company's will get more expensive. CELG still cheap, will get to $152 in less than a year per JMP Securities. Just make an offer now, some very good Co's out there that would be accretive to earnings in o time. Risk/Reward never been better.
Hi bite, badass, Alex, Ray or whomever you are. Open label, I'll take a patient by patient update...why not. K data all being done by a 3rd party, tell them to speed it up please. Starting the next Cohort involves approval from Dana Farber to fund. You were like this with P, where is the data? They did, pretty good. Why don't they release the pharmacokinetics (PK) data they did, pretty good. What's your point?
If criminal activity can be proven in CTIX's case, we can use the parties involved for everything they are worth and many millions more.
These are the arguments, same over and over repeated posts on the SA article you were thoroughly schooled on, and have vacated the discussion. As far as K, it does show efficacy. They believe it will show substantial efficacy if K's life in the blood stream is extended and they are determining what method will best do that. Find something to cut and paste again.